The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells

With the emergence of Src inhibitors in clinical trials, improved knowledge of the molecular responses of cancer cells to these agents is warranted. This will facilitate the development of tests to identify patients who may benefit from these agents, allow drug activity to be monitored and rationali...

Full description

Saved in:

Bibliographic Details
Main Authors:	Purnell, P.R., Mack, P.C., Tepper, C.G., Evans, C.P., Green, T.P., Gumerlock, P.H., Lara, P.N., Gandara, D.R., Kung, H.J., Gautschi, O.
Format:	Artigo
Language:	Inglês
Published:	2009
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2716757/ https://ncbi.nlm.nih.gov/pubmed/19240653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31819c78fb
Tags:	Add Tag No Tags, Be the first to tag this record!

The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells

Similar Items